S. Yoshimura

发表

Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.

K. Okamoto, M. Ikeda, M. Motomura, 2015, Internal medicine.

Preoperative risks of post-operative myasthenic crisis (POMC): A meta-analysis

T. Ishii, M. Motomura, M. Aoki, 2019, Journal of the Neurological Sciences.

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis

M. Motomura, A. Kawakami, A. Tsujino, 2015, BMJ Open.

Biomarkers of Cardiac Dysfunction as Risk Factors in Cryptogenic Stroke

K. Maemura, A. Tsujino, A. Tsuneto, 2019, Cerebrovascular Diseases.

FTY720 Exacerbates Blood–Brain Barrier Dysfunction Induced by IgG Derived from Patients with NMO and MOG Disease

A. Tsujino, Toshiyuki Takahashi, Keiko Tanaka, 2021, Neurotoxicity Research.

Two cases of refractory polymyositis accompanied with steroid myopathy

K. Migita, K. Eguchi, M. Motomura, 2013, Modern rheumatology.

Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies

G. Ricken, H. Shintaku, M. Motomura, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Modified method of intravenous immunoglobulin administration for patients with intractable multifocal motor neuropathy: A case report

S. Kusunoki, Y. Ando, M. Motomura, 2017 .

Two novel VCP missense variants identified in Japanese patients with multisystem proteinopathy

I. Nonaka, Y. Hayashi, I. Nishino, 2018, Human Genome Variation.

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

An adult case of parainfectious optic neuritis associated with genital herpes simplex virus type 2 infection

T. Kitaoka, A. Tsujino, S. Yoshimura, 2020, Clinical Neurology and Neurosurgery.

HTLV-I virological and histopathological analysis in two cases of anti-centromere-antibody-seropositive Sjögren’s syndrome

S. Yamasaki, K. Ichinose, Hideki Nakamura, 2013, Modern rheumatology.

A Case of Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome as an Initial Manifestation.

A. Tsujino, Y. Tateishi, T. Kanamoto, 2020, Internal medicine.

Delayed recurrent posterior circulation infarction after C1-C2 posterior fusion treated with endovascular parent artery occlusion: a case report

A. Tsujino, Y. Tateishi, T. Kanamoto, 2021, Japanese Journal of Stroke.

GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.

T. Kanda, M. Motomura, H. Nishihara, 2019, Brain : a journal of neurology.

Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients

Hideki Nakamura, A. Kawakami, Tomayoshi Hayashi, 2016, Modern rheumatology.

M. Motomura, Tomayoshi Hayashi, Minoru Hara, 2016, Rinsho shinkeigaku = Clinical neurology.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

Respiratory movement in Ondine’s curse after unilateral medullary infarction: A case report

A. Tsujino, Y. Tateishi, T. Kanamoto, 2020 .

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adam L. Comer, Robert G. Miller, S. Demeret, 2023, The Lancet Neurology.

Impact of width of susceptibility vessel sign on recanalization following endovascular therapy

Y. Tomita, M. Morikawa, Y. Tateishi, 2023, Journal of the Neurological Sciences.

Two novel VCP missense variants identified in Japanese patients with multisystem proteinopathy

I. Nonaka, Y. Hayashi, I. Nishino, 2018, Human Genome Variation.

A score using left ventricular diastolic dysfunction to predict 90-day mortality in acute ischemic stroke: The DONE score

K. Maemura, A. Tsujino, A. Tsuneto, 2019, Journal of the Neurological Sciences.

Morphologic Features of Carotid Plaque Rupture Assessed by Optical Coherence Tomography

T. Iwama, M. Kawasaki, Y. Ando, 2015, American Journal of Neuroradiology.

Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors

M. Motomura, N. Kohara, H. Yamasaki, 2021, Internal medicine.

Autoimmunity to voltage‐gated calcium channels

M. Motomura, H. Shiraishi, S. Yoshimura, 2023, Neurology and Clinical Neuroscience.